Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 65862-036

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 65862-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (150 mg/300 mg (60 Tablet Bottle))

This is a description of a medication labeled as the NDC 65862-036-60. The medication contains Lamivudine and Zidovudine in film-coated tablets. Each tablet consists of 150 mg of lamivudine USP and 300 mg of zidovudine USP. The usual dosage information can be found in the prescribing information, and it should not be used if the safety seal is broken or missing. This medication should be stored at a temperature range of 20° to 25°C (66° to 77°F); excursions are permitted to 15° to 30°C (59° o 86°F). It is distributed by Aurobindo Pharma USA, Inc. and made in India.*

FDA Label Image

Lamizido Fig2

This is a description of a prescription drug labeled "Lamivudine and Zidovudine Tablets USP," containing 150 mg of lamivudine and 300 mg of zidovudine in each film-coated tablet. It is distributed in the US by Aurobindo Pharma USA and should be stored at room temperature. The usual dosage is available in the prescribing information. The NDC number is 65862-036-10.*

FDA Label Image

Chemical Structure Lamivudine (Lamizido Str1)

FDA Label Image

Chemical Structure Zidovudine (Lamizido Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.